-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dazdotuftide in Glaucoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dazdotuftide in Glaucoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dazdotuftide in Glaucoma Drug Details: dazdotuftide (TRS-01) is under development for treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lanadelumab in Angioedema
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lanadelumab in Angioedema report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lanadelumab in Angioedema Drug Details: Lanadelumab (Takhzyro) recombinant, fully human, monoclonal antibody...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pelabresib in Myelofibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pelabresib in Myelofibrosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pelabresib in Myelofibrosis Drug Details: Pelabresib (CPI-0610) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – XSTEM in Osteoarthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - XSTEM in Osteoarthritis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. XSTEM in Osteoarthritis Drug Details: XSTEM is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ozekibart in Sarcomas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ozekibart in Sarcomas report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ozekibart in Sarcomas Drug Details: INBRX-109 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AT-002 in Uveitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AT-002 in Uveitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AT-002 in Uveitis Drug Details: AT-002 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AT-002 in Dermatomyositis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AT-002 in Dermatomyositis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AT-002 in Dermatomyositis Drug Details: AT-002 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Denosumab in Osteoarthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Denosumab in Osteoarthritis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Denosumab in Osteoarthritis Drug Details: Denosumab (Prolia, Pralia), is a human IgG2...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vismodegib in Meningioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vismodegib in Meningioma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vismodegib in Meningioma Drug Details: Vismodegib (Erivedge) belongs to the class of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Glycopyrrolate in Asthma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Glycopyrrolate in Asthma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Glycopyrrolate in Asthma Drug Details: Glycopyrronium bromide (Seebri / NVA237 / AD237...